Pulmonary hypertension (PH) associated with left heart disease, or Group 2 PH, includes
heart failure, valvular heart diseases, and congenital heart diseases. Although it is axiomatic …

Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …

The COVID-19 pandemic presents many unique challenges when caring for patients with
pulmonary hypertension. The COVID-19 pandemic has altered routine standard of care …

According to the US Centers for Disease Control and Prevention (CDC), patients with
underlying health conditions, including all types of lung and cardiovascular diseases, have …

Background: The functional adaptation of the right ventricle (RV) to the different degrees of
left ventricular (LV) dysfunction remains to be clarified. We sought to (1) assess the changes …

Background Right ventricular (RV) dysfunction in sepsis and septic shock has been
infrequently studied and has uncertain prognostic significance. Research Question Does RV …

Heart failure (HF) prevalence remains high worldwide with significant sex-related and
regional differences in its presentation, management, and outcomes. In 2020, advances in …

Aims Right ventricular (RV) dysfunction, pulmonary hypertension, and exercise intolerance
have prognostic values, but their interrelation is not fully understood. We investigated how …

Objective To determine which clinical variables infer the highest risk for mortality in patients
with notable tricuspid regurgitation (TR) and to develop a clinical assessment tool (the …

Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart
failure and frequently is associated with pulmonary hypertension (PH). HFpEF associated …